55.6
Peter C. Friedman
Skin Specialty Dermatology (United States)
Peter C. Friedman's research has significantly advanced the application of nonthermal atmospheric pressure plasma technology in dermatology. Studies have demonstrated the efficacy of cold atmospheric pressure plasma in clearing molluscum contagiosum and reducing Demodex count on the face, comparable to topical ivermectin treatments. Additionally, a case series using cold plasma to treat warts in children has shown promising results. Furthermore, research on nanosecond-pulsed DBD plasma for treating actinic keratosis is ongoing, with potential implications for improving skin cancer treatment outcomes. Friedman's work also explores the application of plasma technology in addressing nodular tuberculid cases in HIV patients, expanding its therapeutic potential.